0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Methotrexate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-14H2457
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Methotrexate Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Methotrexate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-14H2457
Report
August 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Methotrexate- Market Size

The global market for Methotrexate was estimated to be worth US$ 545 million in 2024 and is forecast to a readjusted size of US$ 655 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.

Methotrexate- Market

Methotrexate- Market

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
This report aims to provide a comprehensive presentation of the global market for Methotrexate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Methotrexate by region & country, by Type, and by Application.
The Methotrexate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate.
Market Segmentation

Scope of Methotrexate- Market Report

Report Metric Details
Report Name Methotrexate- Market
Forecasted market size in 2031 US$ 655 million
CAGR 2.7%
Forecasted years 2025 - 2031
Segment by Type
  • Methotrexate for Injection
  • Methotrexate Tablets
Segment by Application
  • Used for Cancers
  • Used for Rheumatoid Arthritis
  • Used for Other Diseases
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Methotrexate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Methotrexate in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Methotrexate- Market size in 2031?

Ans: The Methotrexate- Market size in 2031 will be US$ 655 million.

What is the Methotrexate- Market share by region?

Ans: North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.

What is the market share of major companies in Methotrexate- Market?

Ans: Top 3 companies occupied about 65% market share.

Who are the main players in the Methotrexate- Market report?

Ans: The main players in the Methotrexate- Market are Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu

What are the Application segmentation covered in the Methotrexate- Market report?

Ans: The Applications covered in the Methotrexate- Market report are Used for Cancers, Used for Rheumatoid Arthritis, Used for Other Diseases

What are the Type segmentation covered in the Methotrexate- Market report?

Ans: The Types covered in the Methotrexate- Market report are Methotrexate for Injection, Methotrexate Tablets

Recommended Reports

Cancer Therapies

Arthritis & Autoimmune

Hematology Therapeutics

1 Market Overview
1.1 Methotrexate Product Introduction
1.2 Global Methotrexate Market Size Forecast
1.2.1 Global Methotrexate Sales Value (2020-2031)
1.2.2 Global Methotrexate Sales Volume (2020-2031)
1.2.3 Global Methotrexate Sales Price (2020-2031)
1.3 Methotrexate Market Trends & Drivers
1.3.1 Methotrexate Industry Trends
1.3.2 Methotrexate Market Drivers & Opportunity
1.3.3 Methotrexate Market Challenges
1.3.4 Methotrexate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Methotrexate Players Revenue Ranking (2024)
2.2 Global Methotrexate Revenue by Company (2020-2025)
2.3 Global Methotrexate Players Sales Volume Ranking (2024)
2.4 Global Methotrexate Sales Volume by Company Players (2020-2025)
2.5 Global Methotrexate Average Price by Company (2020-2025)
2.6 Key Manufacturers Methotrexate Manufacturing Base and Headquarters
2.7 Key Manufacturers Methotrexate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Methotrexate
2.9 Methotrexate Market Competitive Analysis
2.9.1 Methotrexate Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Methotrexate Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methotrexate as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Methotrexate for Injection
3.1.2 Methotrexate Tablets
3.2 Global Methotrexate Sales Value by Type
3.2.1 Global Methotrexate Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Methotrexate Sales Value, by Type (2020-2031)
3.2.3 Global Methotrexate Sales Value, by Type (%) (2020-2031)
3.3 Global Methotrexate Sales Volume by Type
3.3.1 Global Methotrexate Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Methotrexate Sales Volume, by Type (2020-2031)
3.3.3 Global Methotrexate Sales Volume, by Type (%) (2020-2031)
3.4 Global Methotrexate Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Used for Cancers
4.1.2 Used for Rheumatoid Arthritis
4.1.3 Used for Other Diseases
4.2 Global Methotrexate Sales Value by Application
4.2.1 Global Methotrexate Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Methotrexate Sales Value, by Application (2020-2031)
4.2.3 Global Methotrexate Sales Value, by Application (%) (2020-2031)
4.3 Global Methotrexate Sales Volume by Application
4.3.1 Global Methotrexate Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Methotrexate Sales Volume, by Application (2020-2031)
4.3.3 Global Methotrexate Sales Volume, by Application (%) (2020-2031)
4.4 Global Methotrexate Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Methotrexate Sales Value by Region
5.1.1 Global Methotrexate Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Methotrexate Sales Value by Region (2020-2025)
5.1.3 Global Methotrexate Sales Value by Region (2026-2031)
5.1.4 Global Methotrexate Sales Value by Region (%), (2020-2031)
5.2 Global Methotrexate Sales Volume by Region
5.2.1 Global Methotrexate Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Methotrexate Sales Volume by Region (2020-2025)
5.2.3 Global Methotrexate Sales Volume by Region (2026-2031)
5.2.4 Global Methotrexate Sales Volume by Region (%), (2020-2031)
5.3 Global Methotrexate Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Methotrexate Sales Value, 2020-2031
5.4.2 North America Methotrexate Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Methotrexate Sales Value, 2020-2031
5.5.2 Europe Methotrexate Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Methotrexate Sales Value, 2020-2031
5.6.2 Asia Pacific Methotrexate Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Methotrexate Sales Value, 2020-2031
5.7.2 South America Methotrexate Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Methotrexate Sales Value, 2020-2031
5.8.2 Middle East & Africa Methotrexate Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Methotrexate Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Methotrexate Sales Value
6.2.1 Key Countries/Regions Methotrexate Sales Value, 2020-2031
6.2.2 Key Countries/Regions Methotrexate Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Methotrexate Sales Value, 2020-2031
6.3.2 United States Methotrexate Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Methotrexate Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Methotrexate Sales Value, 2020-2031
6.4.2 Europe Methotrexate Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Methotrexate Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Methotrexate Sales Value, 2020-2031
6.5.2 China Methotrexate Sales Value by Type (%), 2024 VS 2031
6.5.3 China Methotrexate Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Methotrexate Sales Value, 2020-2031
6.6.2 Japan Methotrexate Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Methotrexate Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Methotrexate Sales Value, 2020-2031
6.7.2 South Korea Methotrexate Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Methotrexate Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Methotrexate Sales Value, 2020-2031
6.8.2 Southeast Asia Methotrexate Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Methotrexate Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Methotrexate Sales Value, 2020-2031
6.9.2 India Methotrexate Sales Value by Type (%), 2024 VS 2031
6.9.3 India Methotrexate Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Teva Pharmaceutical Industries
7.1.1 Teva Pharmaceutical Industries Company Information
7.1.2 Teva Pharmaceutical Industries Introduction and Business Overview
7.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Teva Pharmaceutical Industries Methotrexate Product Offerings
7.1.5 Teva Pharmaceutical Industries Recent Development
7.2 Qualitestrx (DAVA Pharmaceuticals)
7.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
7.2.2 Qualitestrx (DAVA Pharmaceuticals) Introduction and Business Overview
7.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Offerings
7.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Development
7.3 Pfizer (Hospira)
7.3.1 Pfizer (Hospira) Company Information
7.3.2 Pfizer (Hospira) Introduction and Business Overview
7.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Pfizer (Hospira) Methotrexate Product Offerings
7.3.5 Pfizer (Hospira) Recent Development
7.4 Roxane Laboratories
7.4.1 Roxane Laboratories Company Information
7.4.2 Roxane Laboratories Introduction and Business Overview
7.4.3 Roxane Laboratories Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Roxane Laboratories Methotrexate Product Offerings
7.4.5 Roxane Laboratories Recent Development
7.5 Sine
7.5.1 Sine Company Information
7.5.2 Sine Introduction and Business Overview
7.5.3 Sine Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sine Methotrexate Product Offerings
7.5.5 Sine Recent Development
7.6 Maoxiang
7.6.1 Maoxiang Company Information
7.6.2 Maoxiang Introduction and Business Overview
7.6.3 Maoxiang Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Maoxiang Methotrexate Product Offerings
7.6.5 Maoxiang Recent Development
7.7 LingNan Pharmaceutical
7.7.1 LingNan Pharmaceutical Company Information
7.7.2 LingNan Pharmaceutical Introduction and Business Overview
7.7.3 LingNan Pharmaceutical Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 LingNan Pharmaceutical Methotrexate Product Offerings
7.7.5 LingNan Pharmaceutical Recent Development
7.8 Powerdone
7.8.1 Powerdone Company Information
7.8.2 Powerdone Introduction and Business Overview
7.8.3 Powerdone Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Powerdone Methotrexate Product Offerings
7.8.5 Powerdone Recent Development
7.9 Huiyu
7.9.1 Huiyu Company Information
7.9.2 Huiyu Introduction and Business Overview
7.9.3 Huiyu Methotrexate Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Huiyu Methotrexate Product Offerings
7.9.5 Huiyu Recent Development
8 Industry Chain Analysis
8.1 Methotrexate Industrial Chain
8.2 Methotrexate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Methotrexate Sales Model
8.5.2 Sales Channel
8.5.3 Methotrexate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Methotrexate Market Trends
 Table 2. Methotrexate Market Drivers & Opportunity
 Table 3. Methotrexate Market Challenges
 Table 4. Methotrexate Market Restraints
 Table 5. Global Methotrexate Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Methotrexate Revenue Market Share by Company (2020-2025)
 Table 7. Global Methotrexate Sales Volume by Company (2020-2025) & (Kg)
 Table 8. Global Methotrexate Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Methotrexate Price by Company (2020-2025) & (USD/Kg)
 Table 10. Key Manufacturers Methotrexate Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Methotrexate Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Methotrexate
 Table 13. Global Methotrexate Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methotrexate as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Methotrexate Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Methotrexate Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Methotrexate Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Methotrexate Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Methotrexate Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Methotrexate Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
 Table 22. Global Methotrexate Sales Volume by Type (2020-2025) & (Kg)
 Table 23. Global Methotrexate Sales Volume by Type (2026-2031) & (Kg)
 Table 24. Global Methotrexate Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Methotrexate Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Methotrexate Price by Type (2020-2025) & (USD/Kg)
 Table 27. Global Methotrexate Price by Type (2026-2031) & (USD/Kg)
 Table 28. Global Methotrexate Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Methotrexate Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Methotrexate Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Methotrexate Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Methotrexate Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Methotrexate Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
 Table 34. Global Methotrexate Sales Volume by Application (2020-2025) & (Kg)
 Table 35. Global Methotrexate Sales Volume by Application (2026-2031) & (Kg)
 Table 36. Global Methotrexate Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Methotrexate Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Methotrexate Price by Application (2020-2025) & (USD/Kg)
 Table 39. Global Methotrexate Price by Application (2026-2031) & (USD/Kg)
 Table 40. Global Methotrexate Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Methotrexate Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Methotrexate Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Methotrexate Sales Value by Region (2020-2025) & (%)
 Table 44. Global Methotrexate Sales Value by Region (2026-2031) & (%)
 Table 45. Global Methotrexate Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
 Table 46. Global Methotrexate Sales Volume by Region (2020-2025) & (Kg)
 Table 47. Global Methotrexate Sales Volume by Region (2026-2031) & (Kg)
 Table 48. Global Methotrexate Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Methotrexate Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Methotrexate Average Price by Region (2020-2025) & (USD/Kg)
 Table 51. Global Methotrexate Average Price by Region (2026-2031) & (USD/Kg)
 Table 52. Key Countries/Regions Methotrexate Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Methotrexate Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Methotrexate Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Methotrexate Sales Volume, (2020-2025) & (Kg)
 Table 56. Key Countries/Regions Methotrexate Sales Volume, (2026-2031) & (Kg)
 Table 57. Teva Pharmaceutical Industries Company Information
 Table 58. Teva Pharmaceutical Industries Introduction and Business Overview
 Table 59. Teva Pharmaceutical Industries Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 60. Teva Pharmaceutical Industries Methotrexate Product Offerings
 Table 61. Teva Pharmaceutical Industries Recent Development
 Table 62. Qualitestrx (DAVA Pharmaceuticals) Company Information
 Table 63. Qualitestrx (DAVA Pharmaceuticals) Introduction and Business Overview
 Table 64. Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 65. Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Offerings
 Table 66. Qualitestrx (DAVA Pharmaceuticals) Recent Development
 Table 67. Pfizer (Hospira) Company Information
 Table 68. Pfizer (Hospira) Introduction and Business Overview
 Table 69. Pfizer (Hospira) Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 70. Pfizer (Hospira) Methotrexate Product Offerings
 Table 71. Pfizer (Hospira) Recent Development
 Table 72. Roxane Laboratories Company Information
 Table 73. Roxane Laboratories Introduction and Business Overview
 Table 74. Roxane Laboratories Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 75. Roxane Laboratories Methotrexate Product Offerings
 Table 76. Roxane Laboratories Recent Development
 Table 77. Sine Company Information
 Table 78. Sine Introduction and Business Overview
 Table 79. Sine Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 80. Sine Methotrexate Product Offerings
 Table 81. Sine Recent Development
 Table 82. Maoxiang Company Information
 Table 83. Maoxiang Introduction and Business Overview
 Table 84. Maoxiang Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 85. Maoxiang Methotrexate Product Offerings
 Table 86. Maoxiang Recent Development
 Table 87. LingNan Pharmaceutical Company Information
 Table 88. LingNan Pharmaceutical Introduction and Business Overview
 Table 89. LingNan Pharmaceutical Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 90. LingNan Pharmaceutical Methotrexate Product Offerings
 Table 91. LingNan Pharmaceutical Recent Development
 Table 92. Powerdone Company Information
 Table 93. Powerdone Introduction and Business Overview
 Table 94. Powerdone Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 95. Powerdone Methotrexate Product Offerings
 Table 96. Powerdone Recent Development
 Table 97. Huiyu Company Information
 Table 98. Huiyu Introduction and Business Overview
 Table 99. Huiyu Methotrexate Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 100. Huiyu Methotrexate Product Offerings
 Table 101. Huiyu Recent Development
 Table 102. Key Raw Materials Lists
 Table 103. Raw Materials Key Suppliers Lists
 Table 104. Methotrexate Downstream Customers
 Table 105. Methotrexate Distributors List
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources


List of Figures
 Figure 1. Methotrexate Product Picture
 Figure 2. Global Methotrexate Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Methotrexate Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Methotrexate Sales Volume (2020-2031) & (Kg)
 Figure 5. Global Methotrexate Sales Price (2020-2031) & (USD/Kg)
 Figure 6. Methotrexate Report Years Considered
 Figure 7. Global Methotrexate Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Methotrexate Players Sales Volume Ranking (2024) & (Kg)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Methotrexate Revenue in 2024
 Figure 10. Methotrexate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Methotrexate for Injection Picture
 Figure 12. Methotrexate Tablets Picture
 Figure 13. Global Methotrexate Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Methotrexate Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Methotrexate Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
 Figure 16. Global Methotrexate Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Methotrexate Price by Type (2020-2031) & (USD/Kg)
 Figure 18. Product Picture of Used for Cancers
 Figure 19. Product Picture of Used for Rheumatoid Arthritis
 Figure 20. Product Picture of Used for Other Diseases
 Figure 21. Global Methotrexate Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Methotrexate Sales Value Market Share by Application, 2024 & 2031
 Figure 23. Global Methotrexate Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
 Figure 24. Global Methotrexate Sales Volume Market Share by Application, 2024 & 2031
 Figure 25. Global Methotrexate Price by Application (2020-2031) & (USD/Kg)
 Figure 26. North America Methotrexate Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Methotrexate Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Methotrexate Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Methotrexate Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Methotrexate Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Methotrexate Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Methotrexate Sales Value (%), (2020-2031)
 Figure 37. Key Countries/Regions Methotrexate Sales Volume (%), (2020-2031)
 Figure 38. United States Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 39. United States Methotrexate Sales Value by Type (%), 2024 VS 2031
 Figure 40. United States Methotrexate Sales Value by Application (%), 2024 VS 2031
 Figure 41. Europe Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 42. Europe Methotrexate Sales Value by Type (%), 2024 VS 2031
 Figure 43. Europe Methotrexate Sales Value by Application (%), 2024 VS 2031
 Figure 44. China Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 45. China Methotrexate Sales Value by Type (%), 2024 VS 2031
 Figure 46. China Methotrexate Sales Value by Application (%), 2024 VS 2031
 Figure 47. Japan Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 48. Japan Methotrexate Sales Value by Type (%), 2024 VS 2031
 Figure 49. Japan Methotrexate Sales Value by Application (%), 2024 VS 2031
 Figure 50. South Korea Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 51. South Korea Methotrexate Sales Value by Type (%), 2024 VS 2031
 Figure 52. South Korea Methotrexate Sales Value by Application (%), 2024 VS 2031
 Figure 53. Southeast Asia Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Methotrexate Sales Value by Type (%), 2024 VS 2031
 Figure 55. Southeast Asia Methotrexate Sales Value by Application (%), 2024 VS 2031
 Figure 56. India Methotrexate Sales Value, (2020-2031) & (US$ Million)
 Figure 57. India Methotrexate Sales Value by Type (%), 2024 VS 2031
 Figure 58. India Methotrexate Sales Value by Application (%), 2024 VS 2031
 Figure 59. Methotrexate Industrial Chain
 Figure 60. Methotrexate Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS